- Home
- RGEN vs CMA Comparison
RGEN vs CMA Comparison
Compare RGEN & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- CMA
- Stock Information
- Founded
- RGEN 1981
- CMA 1849
- Country
- RGEN United States
- CMA United States
- Employees
- RGEN N/A
- CMA N/A
- Industry
- RGEN Medical/Dental Instruments
- CMA Major Banks
- Sector
- RGEN Health Care
- CMA Finance
- Exchange
- RGEN Nasdaq
- CMA Nasdaq
- Market Cap
- RGEN 8.0B
- CMA 7.1B
- IPO Year
- RGEN N/A
- CMA N/A
- Fundamental
- Price
- RGEN $118.15
- CMA $56.17
- Analyst Decision
- RGEN Buy
- CMA Hold
- Analyst Count
- RGEN 12
- CMA 20
- Target Price
- RGEN $172.67
- CMA $61.55
- AVG Volume (30 Days)
- RGEN 819.3K
- CMA 1.3M
- Earning Date
- RGEN 04-29-2025
- CMA 07-18-2025
- Dividend Yield
- RGEN N/A
- CMA 5.05%
- EPS Growth
- RGEN N/A
- CMA 4.95
- EPS
- RGEN N/A
- CMA 5.29
- Revenue
- RGEN $650,429,000.00
- CMA $3,234,000,000.00
- Revenue This Year
- RGEN $13.93
- CMA $7.20
- Revenue Next Year
- RGEN $14.35
- CMA $3.01
- P/E Ratio
- RGEN N/A
- CMA $10.64
- Revenue Growth
- RGEN 4.88
- CMA N/A
- 52 Week Low
- RGEN $102.97
- CMA $45.32
- 52 Week High
- RGEN $182.52
- CMA $73.45
- Technical
- Relative Strength Index (RSI)
- RGEN 38.20
- CMA 49.43
- Support Level
- RGEN $120.11
- CMA $57.70
- Resistance Level
- RGEN $129.42
- CMA $59.13
- Average True Range (ATR)
- RGEN 6.02
- CMA 1.08
- MACD
- RGEN -1.20
- CMA -0.02
- Stochastic Oscillator
- RGEN 5.96
- CMA 35.43
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.